Case Report

Recently published articles about Case Report

PCC
Benzodiazepine-Induced Neurologic Dysfunction
Case Report

November 27, 2025

This case illustrates how benzodiazepine-induced neurologic dysfunction and benzodiazepine use disorder can coexist, emphasizing the importance of distinguishing between them to guide diagnosis and management.
,
PCC
From Varenicline to Neuroleptic Malignant Syndrome
Case Report

November 27, 2025

This case highlights the complexity of diagnosing atypical neuroleptic malignant syndrome in high-risk individuals after sudden cessation of varenicline and cigarette smoking.
,
PCC
Comorbidities Obscure Autism Diagnosis
Case Report

November 25, 2025

A 14-year-old boy with longstanding psychotic illness, posttraumatic stress from adverse social experiences, and suicidality presented for neuropsychiatric assessment.
PCC
Psychosis or Multiple System Atrophy?
Case Report

November 20, 2025

A 67-year-old woman presented with altered mental status, hallucinations, and hyperalgesia of the bilateral lower legs and was subsequently diagnosed with multiple system atrophy.
, , , et al
PCC
Religious Preoccupation in Adolescence
Case Report

November 18, 2025

A 16-year-old boy developed new-onset psychosis of religious preoccupation and delusions.
, , , et al
PCC
Clozapine Withdrawal–Induced Catatonia
Case Report

November 18, 2025

A patient with treatment-resistant schizophrenia developed persistent catatonia after sudden cessation of clozapine, highlighting the challenges in management and the potential role of clozapine reintroduction.
, , , et al

Recent JCP Articles on Case Report

JCP
Burnout in Psychiatric Doctors Before and After COVID-19: A Critical Commentary
Letter to the Editor

December 1, 2025

The authors comment on a recent meta-analysis by Johnson and colleagues.
,
JCP
The Goldilocks Problem: Balancing Internal Validity with Generalizability in Clinical Trials
Commentary

November 26, 2025

The author discusses a recent analysis by Zimmerman and Snyder focusing on the generalizability of PTSD treatment trials.
JCP
Lack of Generalizability of PTSD Treatment Trials: The Recent Brexpiprazole-Sertraline Trials as an Example
Original Research

November 26, 2025

In an outpatient psychiatry sample, nearly 95% of patients who want treatment for PTSD would not have qualified for the trials of brexpiprazole-sertraline for PTSD.
,

Recent PCC Articles on Case Report

PCC
Sequelae of Toxic Exposures in Veterans
Rounds in the General Hospital

November 25, 2025

A 45-year-old veteran has ongoing symptoms likely related to past exposure to burn pits, dust storms, airborne industrial pollutants, and head trauma from hard parachute landings.
, , , et al
PCC
Impact of Patient Suicide on Mental Health Professionals
Original Research

November 20, 2025

Patient suicide can cause lasting emotional and professional distress in mental health professionals due to their unique relationship with the patient.
, , , et al
PCC
Lumateperone-Induced Urticarial Rash in Schizophrenia
Case Report

November 13, 2025

This report describes an instance of acute generalized urticaria immediately following an initial dose of lumateperone in a 43-year-old man with schizophrenia.
, ,

Featured Case Report Research

Otsuka Seeks FDA Approval for New ADHD Drug
news

December 1, 2025

Otsuka has asked the FDA to approve centanafadine, a new ADHD drug backed by strong Phase 3 data across children, adolescents, and adults.
Can a Superhero Make Us Kinder?
news

November 26, 2025

A brief subway experiment in Italy found that a superhero’s unexpected presence nudged riders to act more kindly.
JCP
MAOI Antidepressants: A History Being Rewritten
Commentary

November 26, 2025

Members of the International MAOI Expert Group discuss historical use of MAOIs, consider their efficacy and safety, and underscore the importance of reassessing their place in treatment algorithms.
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe